Experimental data from Chen et al. demonstrated that 5-FU mediated the PUMA/RIPK3 signaling pathway to regulate necrotic apoptosis in order to enhance tumor cell killing and anti-tumorimmune responses, thus improving CRC treatment, thereby improving the treatment of CRC (Chen et al., 2024). The gene discussed is RIPK3; the disease is neoplasm.